Skip to content

Study of Provider Computer Alerts Designed to Improve Delivery of HIV Care

Optimizing HIV Disease-Specific Provider Alerts: A Randomized Controlled Informatics Trial Comparing Electronic Health Record (EHR) vs. Non-EHR Provider Alerts

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00678600
Enrollment
1011
Registered
2008-05-15
Start date
2007-09-30
Completion date
2008-12-31
Last updated
2013-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections

Keywords

Informatics, Alerts, Toxicity, Virologic failure, Suboptimal follow up

Brief summary

The purpose of this study is to determine whether alerts independent of the ambulatory health record are more effective in eliciting physician responses and therefore have greater impact on HIV disease outcomes than traditional static alerts.

Detailed description

This study will compare the effectiveness of standard and enhanced care alerts in HIV infected participants at Massachusetts General Hospital in Boston, Massachusetts. Participants will be a part of this study for 4 years or until they are no longer followed at Massachusetts General Hospital. Participants will be assigned randomly to one of two arms. Participants assigned to Arm 1 will receive standard care, involving standard provider alerts which will be posted on the participant's health record. Participants assigned to Arm 2 will receive enhanced care, involving improved functionality. Experimental informatics-based provider alerts and support systems will be used to develop a pilot system designed to optimize delivery of HIV clinical care. All participants will be monitored for new laboratory toxicities, suboptimal follow up, and virologic failure at their normally scheduled appointments.

Interventions

OTHERStandard (static) Computer Alerts

Static Computer Alerts on Patient's EMR webpage.

OTHEREnhanced Computer Alerts

Population level and asynchronous alerts with enhanced functionality

Sponsors

Harvard Medical School (HMS and HSDM)
CollaboratorOTHER
Massachusetts General Hospital
CollaboratorOTHER
National Institute of Allergy and Infectious Diseases (NIAID)
Lead SponsorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* HIV infected * Followed in the Massachusetts General Hospital HIV clinic.

Design outcomes

Primary

MeasureTime frame
Change in CD4 countThroughout study

Secondary

MeasureTime frame
Time to repeat laboratory testingThroughout study
Time to follow up appointmentThroughout study

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026